136 related articles for article (PubMed ID: 5631482)
1. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
Horváth IP; Institóris L
Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
[No Abstract] [Full Text] [Related]
2. Mechanism of inactivation of DNA and RNA bacteriophages by alkylating agents in vitro.
Yamamoto N; Naito T; Shimkin MB
Cancer Res; 1966 Nov; 26(11):2301-6. PubMed ID: 5956634
[No Abstract] [Full Text] [Related]
3. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM).
Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S
Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515
[No Abstract] [Full Text] [Related]
4. [Molecular mechanism of the toxic action of alkylating agents].
Verly WG; Brakier L
Rev Eur Etud Clin Biol; 1970 May; 15(5):483-8. PubMed ID: 5430154
[No Abstract] [Full Text] [Related]
5. The mechanisms of action of antitumor compounds.
Belousova AK
Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
[No Abstract] [Full Text] [Related]
6. [Repair of DNA-protein cross-links induced by antineoplastic alkylating agents].
Lomova TIu; Shakhova IK; Shkodinskaia EN
Biull Eksp Biol Med; 1981 Jul; 92(7):74-6. PubMed ID: 7295949
[TBL] [Abstract][Full Text] [Related]
7. Chemistry of DNA alkylation and aralkylation.
Dipple A; Moschel RC
Prog Clin Biol Res; 1990; 340A():71-80. PubMed ID: 2201980
[No Abstract] [Full Text] [Related]
8. The biology of alkylating-agent cellular injury.
Shulman LN
Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-35. PubMed ID: 8468267
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative evaluation of the blood-depressing action of alkylating agents].
Kireeva IV; Khomchenovskiĭ EI; Pykhtina AA
Farmakol Toksikol; 1982; 45(5):90-3. PubMed ID: 7140963
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
Creech HJ; Preston RK; Peck RM; O'Connell AP
J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
[No Abstract] [Full Text] [Related]
11. Regular character of chromatin degradation in lymphoid tissues after treatment with biological alkylating agents in vivo.
Matyásová J; Skalka M; Cejková M
Folia Biol (Praha); 1979; 25(6):380-8. PubMed ID: 583277
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of action of antineoplastic agents].
Korolkovas A
Rev Farm Bioquim Univ Sao Paulo; 1971; 9(1):1-60. PubMed ID: 4948630
[No Abstract] [Full Text] [Related]
13. Chromosome aberrations induced in human leukocytes by the antitumour multipeptide compound "peptichemio". A light and electronmicroscopic study.
Ruzicka F; Nowotny H
Mikroskopie; 1973 Dec; 29(11):325-30. PubMed ID: 4777005
[No Abstract] [Full Text] [Related]
14. Attempt to establish a correlation between the alkylation ability and antitumor activity of some bis(2-chloroethyl)aminoethyl esters of carboxylic acids.
Manolov I; Golovinsky EV
Pharmazie; 1988 Mar; 43(3):218-9. PubMed ID: 3380873
[No Abstract] [Full Text] [Related]
15. The comparative effects of a mono- and a bi-functional alkylating agent on recombination in Chlamydomonas reinhardi.
Davies DR
Z Vererbungsl; 1966; 98(1):61-70. PubMed ID: 5983101
[No Abstract] [Full Text] [Related]
16. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
17. New cancerostatics developed in Czechoslovakia. Introductory lecture.
Semonský M
Neoplasma; 1971; 18(5):431-4. PubMed ID: 5171223
[No Abstract] [Full Text] [Related]
18. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
Sugiura K; Merker PC
Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
[No Abstract] [Full Text] [Related]
19. [Experimental studies on the action of various cytostatic substances on the growth of aerobic and anaerobic microorganisms].
Krebs D; Bloss H
Zentralbl Bakteriol Orig; 1966 Aug; 200(4):468-79. PubMed ID: 4169936
[No Abstract] [Full Text] [Related]
20. Acylation: a proposed mechanism of action for various oncolytic agents based on model chemical systems.
Moncrief JW; Heller KS
Cancer Res; 1967 Aug; 27(8):1500-2. PubMed ID: 6047880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
